The quest for improved fractionation and combined modality regimens in head and neck
cancer has also yielded progressively higher rates of toxicity. Time compression of dose …

Quality of life (QOL) has become an increasingly important outcome measure for patient's
undergoing treatment for a wide array of illnesses. QOL is a global construct that reflects a …

This study tests the reliability and validity of the European Organization for Research and
Treatment of Cancer (EORTC) head and neck cancer module (QLQ-H&N35) and version 3.0 …

PURPOSE: Parotid-sparing intensity-modulated radiotherapy (IMRT) for head-and-neck
cancer reduces xerostomia compared with standard RT. To assess potential improvements …

Although quality of life (QOL) is an important treatment outcome in head and neck cancer
(HNC), cross-study comparisons have been hampered by the heterogeneity of measures …

Background Xerostomia can have a significant impact on the quality of life of patients treated
by radiation therapy (RT) for cancer in the head and neck. The first aim of the study was to …

Alterations in taste and smell functions have been reported in cancer patients. Although
these senses are known to be particularly affected by chemotherapy, many features of …

Background: Central neuropathic pain (CNP), pain initiated or caused by a primary lesion or
dysfunction of the central nervous system, occurs in~ 28% of patients with multiple sclerosis …

Background Quality of life (QOL) is an important treatment outcome for head and neck
cancer. Our purpose was to critically review published disease‐specific QOL instruments …

The aim of the present study was to assess the quality of life (QoL) in patients undergoing
surgical therapy for cancer of the lower region of the oral cavity (floor of the mouth and …